This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Advances in the use of mesenchymal stem cells derived from different origins for the treatment of liver diseases
Hong-Li Xue, Wei-Zheng Zeng
Hong-Li Xue, Wei-Zheng Zeng, Department of Gastroenterology, Chengdu Military General Hospital, Chengdu 610083, Sichuan Province, China
Correspondence to: Wei-Zheng Zeng, Professor, Chief Physician, Department of Gastroenterology, Chengdu Military General Hospital, Chengdu 610083, Sichuan Province, China. zengweizheng@163.com
Received: January 16, 2013 Revised: February 25, 2013 Accepted: March 14, 2013 Published online: April 18, 2013
Liver diseases are common and frequent diseases that seriously affect human health and consume social resources. Both the absolute number of patients with liver diseases and their relative incidence in China are the highest in the world. In recent years, encouraging achievements have been achieved in stem cell therapy of chronic liver diseases both in China and abroad. Mesenchymal stem cells are a kind of pluripotent stem cells derived from the mesoderm. They exist not only in the bone marrow but also in other tissues, such as peripheral blood, umbilical cord blood, spongy bone, adipose tissue, synovium, and umbilical cord. In this article we review recent advances in the use of bone marrow mesenchymal stem cells, umbilical cord blood mesenchymal stem cells and umbilical cord mesenchymal stem cells for the treatment of liver diseases.
Citation: Xue HL, Zeng WZ. Advances in the use of mesenchymal stem cells derived from different origins for the treatment of liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(11): 990-995
Fridenshteĭn AIa, Piatetskiĭ-Shapiro II, Petrakova KV. [Osteogenesis in transplants of bone marrow cells].Arkh Anat Gistol Embriol. 1969;56:3-11.
[PubMed] [DOI]
Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells.Science. 1999;284:1168-1170.
[PubMed] [DOI]
Chivu M, Dima SO, Stancu CI, Dobrea C, Uscatescu V, Necula LG, Bleotu C, Tanase C, Albulescu R, Ardeleanu C. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors.Transl Res. 2009;154:122-132.
[PubMed] [DOI]
Tan Y, Xiao EH, Xiao LZ, Yuan YH, Ma C, Shang QL, Bian DJ, Li YH, Chen Z, Chang Q. VEGF(165) expressing bone marrow mesenchymal stem cells differentiate into hepatocytes under HGF and EGF induction in vitro.Cytotechnology. 2012;64:635-647.
[PubMed] [DOI]
Dalakas E, Newsome PN, Boyle S, Brown R, Pryde A, McCall S, Hayes PC, Bickmore WA, Harrison DJ, Plevris JN. Bone marrow stem cells contribute to alcohol liver fibrosis in humans.Stem Cells Dev. 2010;19:1417-1425.
[PubMed] [DOI]
Kaibori M, Adachi Y, Shimo T, Ishizaki M, Matsui K, Tanaka Y, Ohishi M, Araki Y, Okumura T, Nishizawa M. Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein.Transplant Proc. 2012;44:1107-1109.
[PubMed] [DOI]
Cho KA, Ju SY, Cho SJ, Jung YJ, Woo SY, Seoh JY, Han HS, Ryu KH. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow.Cell Biol Int. 2009;33:772-777.
[PubMed] [DOI]
Baba S, Fujii H, Hirose T, Yasuchika K, Azuma H, Hoppo T, Naito M, Machimoto T, Ikai I. Commitment of bone marrow cells to hepatic stellate cells in mouse.J Hepatol. 2004;40:255-260.
[PubMed] [DOI]
Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.Transplantation. 2004;78:83-88.
[PubMed] [DOI]
EI-Ansary M, Mogawer Sh, Abdel-Aziz I, Abdel-Hamid S. Phase Trial: Mesenchymal Stem Cells Transplantation in End Stage Liver Disease.Journal of American Science. 2010;6:135-144.
[PubMed] [DOI]
Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.Stem Cells. 2006;24:2292-2298.
[PubMed] [DOI]
Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SM, Ramzi M, Kakaei F, Namiri M, Malekzadeh R. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.Arch Iran Med. 2011;14:12-17.
[PubMed] [DOI]
Zhao Q, Ren H, Li X, Chen Z, Zhang X, Gong W, Liu Y, Pang T, Han ZC. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.Cytotherapy. 2009;11:414-426.
[PubMed] [DOI]
Kakinuma S, Tanaka Y, Chinzei R, Watanabe M, Shimizu-Saito K, Hara Y, Teramoto K, Arii S, Sato C, Takase K. Human umbilical cord blood as a source of transplantable hepatic progenitor cells.Stem Cells. 2003;21:217-227.
[PubMed] [DOI]
Jung KH, Shin HP, Lee S, Lim YJ, Hwang SH, Han H, Park HK, Chung JH, Yim SV. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model.Liver Int. 2009;29:898-909.
[PubMed] [DOI]
Shi LL, Liu FP, Wang DW. Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis.Am J Med Sci. 2011;342:212-217.
[PubMed] [DOI]
Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys.Stem Cells. 2007;25:319-331.
[PubMed] [DOI]
Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.Stem Cells. 2006;24:781-792.
[PubMed] [DOI]
Ren HY, Zhao QJ, Xing W, Yang SG, Lu SH, Ren Q, Zhang L, Han ZC. [Differentiation of human umbilical cord derived mesenchymal stem cells into low immunogenic and functional hepatocyte-like cells in vitro].Zhongguo Yixue Kexueyuan Xuebao. 2010;32:190-194.
[PubMed] [DOI]
Lin SZ, Chang YJ, Liu JW, Chang LF, Sun LY, Li YS, Luo GH, Liao CH, Chen PH, Chen TM. Transplantation of human Wharton's Jelly-derived stem cells alleviates chemically induced liver fibrosis in rats.Cell Transplant. 2010;19:1451-1463.
[PubMed] [DOI]
Burra P, Arcidiacono D, Bizzaro D, Chioato T, Di Liddo R, Banerjee A, Cappon A, Bo P, Conconi MT, Parnigotto PP. Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury.BMC Gastroenterol. 2012;12:88.
[PubMed] [DOI]
Bahk JY, Piao Z, Jung JH, Han H. Treatment of the end Stage Liver Cirrhosis by Human Umbilical Cord Blood Stem Cells: Preliminary Results.Stem Cells in Clinic and Research. 2011;469-500.
[PubMed] [DOI]
Toupadakis CA, Wong A, Genetos DC, Cheung WK, Borjesson DL, Ferraro GL, Galuppo LD, Leach JK, Owens SD, Yellowley CE. Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue.Am J Vet Res. 2010;71:1237-1245.
[PubMed] [DOI]
Vidal MA, Walker NJ, Napoli E, Borjesson DL. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue.Stem Cells Dev. 2012;21:273-283.
[PubMed] [DOI]
Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.Reproduction. 2012;143:455-468.
[PubMed] [DOI]
Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.Stem Cells. 2007;25:1384-1392.
[PubMed] [DOI]